Global Oral Proteins And Peptides Market Research Report 2022

1 Oral Proteins and Peptides Market Overview
1.1 Product Overview and Scope of Oral Proteins and Peptides
1.2 Oral Proteins and Peptides Segment by Type
1.2.1 Global Oral Proteins and Peptides Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Oral Proteins and Peptides Segment by Application
1.3.1 Global Oral Proteins and Peptides Sales Comparison by Application: (2022-2028)
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Global Oral Proteins and Peptides Market Size Estimates and Forecasts
1.4.1 Global Oral Proteins and Peptides Revenue 2017-2028
1.4.2 Global Oral Proteins and Peptides Sales 2017-2028
1.4.3 Oral Proteins and Peptides Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Proteins and Peptides Market Competition by Manufacturers
2.1 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oral Proteins and Peptides Manufacturing Sites, Area Served, Product Type
2.5 Oral Proteins and Peptides Market Competitive Situation and Trends
2.5.1 Oral Proteins and Peptides Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Proteins and Peptides Players Market Share by Revenue
2.5.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Proteins and Peptides Retrospective Market Scenario by Region
3.1 Global Oral Proteins and Peptides Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oral Proteins and Peptides Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oral Proteins and Peptides Market Facts & Figures by Country
3.3.1 North America Oral Proteins and Peptides Sales by Country
3.3.2 North America Oral Proteins and Peptides Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Oral Proteins and Peptides Market Facts & Figures by Country
3.4.1 Europe Oral Proteins and Peptides Sales by Country
3.4.2 Europe Oral Proteins and Peptides Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Proteins and Peptides Sales by Region
3.5.2 Asia Pacific Oral Proteins and Peptides Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Oral Proteins and Peptides Market Facts & Figures by Country
3.6.1 Latin America Oral Proteins and Peptides Sales by Country
3.6.2 Latin America Oral Proteins and Peptides Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Proteins and Peptides Sales by Country
3.7.2 Middle East and Africa Oral Proteins and Peptides Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oral Proteins and Peptides Historic Market Analysis by Type
4.1 Global Oral Proteins and Peptides Sales Market Share by Type (2017-2022)
4.2 Global Oral Proteins and Peptides Revenue Market Share by Type (2017-2022)
4.3 Global Oral Proteins and Peptides Price by Type (2017-2022)
5 Global Oral Proteins and Peptides Historic Market Analysis by Application
5.1 Global Oral Proteins and Peptides Sales Market Share by Application (2017-2022)
5.2 Global Oral Proteins and Peptides Revenue Market Share by Application (2017-2022)
5.3 Global Oral Proteins and Peptides Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Ironwood & Allergan
6.1.1 Ironwood & Allergan Corporation Information
6.1.2 Ironwood & Allergan Description and Business Overview
6.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
6.1.5 Ironwood & Allergan Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Synergy Pharmaceuticals （Salix）
6.3.1 Synergy Pharmaceuticals （Salix） Corporation Information
6.3.2 Synergy Pharmaceuticals （Salix） Description and Business Overview
6.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio
6.3.5 Synergy Pharmaceuticals （Salix） Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Oral Proteins and Peptides Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Chiasma (Amryt Pharma)
6.5.1 Chiasma (Amryt Pharma) Corporation Information
6.5.2 Chiasma (Amryt Pharma) Description and Business Overview
6.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
6.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates
7 Oral Proteins and Peptides Manufacturing Cost Analysis
7.1 Oral Proteins and Peptides Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Proteins and Peptides
7.4 Oral Proteins and Peptides Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Proteins and Peptides Distributors List
8.3 Oral Proteins and Peptides Customers
9 Oral Proteins and Peptides Market Dynamics
9.1 Oral Proteins and Peptides Industry Trends
9.2 Oral Proteins and Peptides Market Drivers
9.3 Oral Proteins and Peptides Market Challenges
9.4 Oral Proteins and Peptides Market Restraints
10 Global Market Forecast
10.1 Oral Proteins and Peptides Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Proteins and Peptides by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oral Proteins and Peptides by Type (2023-2028)
10.2 Oral Proteins and Peptides Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Proteins and Peptides by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oral Proteins and Peptides by Application (2023-2028)
10.3 Oral Proteins and Peptides Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Proteins and Peptides by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oral Proteins and Peptides by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Oral Proteins and Peptides Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Oral Proteins and Peptides Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Oral Proteins and Peptides Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Oral Proteins and Peptides Market Competitive Situation by Manufacturers in 2021
Table 5. Global Oral Proteins and Peptides Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oral Proteins and Peptides Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Oral Proteins and Peptides Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Oral Proteins and Peptides Average Price (US$/Mg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Oral Proteins and Peptides Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Proteins and Peptides Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Proteins and Peptides as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Proteins and Peptides Sales by Region (2017-2022) & (Kg)
Table 16. Global Oral Proteins and Peptides Sales Market Share by Region (2017-2022)
Table 17. Global Oral Proteins and Peptides Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Oral Proteins and Peptides Revenue Market Share by Region (2017-2022)
Table 19. North America Oral Proteins and Peptides Sales by Country (2017-2022) & (Kg)
Table 20. North America Oral Proteins and Peptides Sales Market Share by Country (2017-2022)
Table 21. North America Oral Proteins and Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)
Table 23. Europe Oral Proteins and Peptides Sales by Country (2017-2022) & (Kg)
Table 24. Europe Oral Proteins and Peptides Sales Market Share by Country (2017-2022)
Table 25. Europe Oral Proteins and Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Oral Proteins and Peptides Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Oral Proteins and Peptides Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2017-2022)
Table 31. Latin America Oral Proteins and Peptides Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Oral Proteins and Peptides Sales Market Share by Country (2017-2022)
Table 33. Latin America Oral Proteins and Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Oral Proteins and Peptides Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)
Table 39. Global Oral Proteins and Peptides Sales by Type (2017-2022) & (Kg)
Table 40. Global Oral Proteins and Peptides Sales Market Share by Type (2017-2022)
Table 41. Global Oral Proteins and Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Oral Proteins and Peptides Revenue Share by Type (2017-2022)
Table 43. Global Oral Proteins and Peptides Price by Type (2017-2022) & (US$/Mg)
Table 44. Global Oral Proteins and Peptides Sales (Kg) by Application (2017-2022)
Table 45. Global Oral Proteins and Peptides Sales Market Share by Application (2017-2022)
Table 46. Global Oral Proteins and Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Oral Proteins and Peptides Revenue Share by Application (2017-2022)
Table 48. Global Oral Proteins and Peptides Price by Application (2017-2022) & (US$/Mg)
Table 49. Ironwood & Allergan Corporation Information
Table 50. Ironwood & Allergan Description and Business Overview
Table 51. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 52. Ironwood & Allergan Oral Proteins and Peptides Product
Table 53. Ironwood & Allergan Recent Developments/Updates
Table 54. Novo Nordisk Corporation Information
Table 55. Novo Nordisk Description and Business Overview
Table 56. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 57. Novo Nordisk Oral Proteins and Peptides Product
Table 58. Novo Nordisk Recent Developments/Updates
Table 59. Synergy Pharmaceuticals （Salix） Corporation Information
Table 60. Synergy Pharmaceuticals （Salix） Description and Business Overview
Table 61. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 62. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product
Table 63. Synergy Pharmaceuticals （Salix） Recent Developments/Updates
Table 64. Novartis Corporation Information
Table 65. Novartis Description and Business Overview
Table 66. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 67. Novartis Oral Proteins and Peptides Product
Table 68. Novartis Recent Developments/Updates
Table 69. Chiasma (Amryt Pharma) Corporation Information
Table 70. Chiasma (Amryt Pharma) Description and Business Overview
Table 71. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 72. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product
Table 73. Chiasma (Amryt Pharma) Recent Developments/Updates
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Oral Proteins and Peptides Distributors List
Table 77. Oral Proteins and Peptides Customers List
Table 78. Oral Proteins and Peptides Market Trends
Table 79. Oral Proteins and Peptides Market Drivers
Table 80. Oral Proteins and Peptides Market Challenges
Table 81. Oral Proteins and Peptides Market Restraints
Table 82. Global Oral Proteins and Peptides Sales Forecast by Type (2023-2028) & (Kg)
Table 83. Global Oral Proteins and Peptides Sales Market Share Forecast by Type (2023-2028)
Table 84. Global Oral Proteins and Peptides Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 85. Global Oral Proteins and Peptides Revenue Market Share Forecast by Type (2023-2028)
Table 86. Global Oral Proteins and Peptides Sales Forecast by Application (2023-2028) & (Kg)
Table 87. Global Oral Proteins and Peptides Sales Market Share Forecast by Application (2023-2028)
Table 88. Global Oral Proteins and Peptides Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. Global Oral Proteins and Peptides Revenue Market Share Forecast by Application (2023-2028)
Table 90. Global Oral Proteins and Peptides Sales Forecast by Region (2023-2028) & (Kg)
Table 91. Global Oral Proteins and Peptides Sales Market Share Forecast by Region (2023-2028)
Table 92. Global Oral Proteins and Peptides Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 93. Global Oral Proteins and Peptides Revenue Market Share Forecast by Region (2023-2028)
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Proteins and Peptides
Figure 2. Global Oral Proteins and Peptides Market Share by Type in 2021 & 2028
Figure 3. Linaclotide Product Picture
Figure 4. Insulin Product Picture
Figure 5. Plecanatide Product Picture
Figure 6. Cyclosporine Product Picture
Figure 7. Octreotide Product Picture
Figure 8. Global Oral Proteins and Peptides Market Share by Application in 2021 & 2028
Figure 9. Gastric & Digestive Disorders
Figure 10. Bone Diseases
Figure 11. Diabetes
Figure 12. Hormonal Disorders
Figure 13. Global Oral Proteins and Peptides Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Proteins and Peptides Market Size (2017-2028) & (US$ Million)
Figure 15. Global Oral Proteins and Peptides Sales (2017-2028) & (Kg)
Figure 16. Oral Proteins and Peptides Sales Share by Manufacturers in 2021
Figure 17. Global Oral Proteins and Peptides Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Oral Proteins and Peptides Players: Market Share by Revenue in 2021
Figure 19. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Oral Proteins and Peptides Sales Market Share by Region (2017-2022)
Figure 21. Global Oral Proteins and Peptides Sales Market Share by Region in 2021
Figure 22. Global Oral Proteins and Peptides Revenue Market Share by Region (2017-2022)
Figure 23. Global Oral Proteins and Peptides Revenue Market Share by Region in 2021
Figure 24. United States Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Taiwan Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Oral Proteins and Peptides Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Oral Proteins and Peptides by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Oral Proteins and Peptides
Figure 48. Manufacturing Process Analysis of Oral Proteins and Peptides
Figure 49. Oral Proteins and Peptides Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.